• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Eli Lilly to buy Novartis Animal Health, merge assets with Elanco

April 22, 2014

$5.4 billion deal to create one of the world's largest veterinary health companies.

A $5.4 billion deal with Swiss pharmaceutical company Novartis International AG is set to make Eli Lilly and Co. the owner of Novartis Animal Health. The all-cash agreement, which combines Novartis assets with Lilly’s existing animal health business, Elanco, will create the second-largest animal health company in the world, executives say.

“This deal creates a global animal health leader able to deliver even more innovation and value to our customers,” says Jeff Simmons, Lilly senior vice president and president of Elanco Animal Health. “Combining these two great companies will enable us to provide more diversified brands, reach more market segments, expand our global footprint, and strengthen our pipeline, capabilities and expertise.”

The deal gives Lilly Novartis Animal Health’s nine manufacturing sites, six dedicated research and development facilities, a portfolio of approximately 600 products, and 40 more projects in development. It also transfers more than 3,000 employees from Novartis Animal Health, which spans 40 countries and last year had revenue of approximately $1.1 billion, to Elanco.

John C. Lechleiter, PhD, Lilly’s chairman, president and CEO, says in a company release that Elanco is a key component of the parent company’s future. “We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses,” Lechleiter says. “Significant investments in our animal health business in recent years have enabled Elanco to double its revenue since 2008, leading the industry in growth.”

Notably, last June Elanco Animal Health entered a deal with Heska Corp., a provider of veterinary diagnostic and specialty products, to buy certain noncore assets useful for the production of bovine and feline vaccines. In the summer of 2011 Elanco acquired Janssen Pharmaceutica, a Johnson & Johnson company, to diversify its food animal portfolio and complement its companion animal business in Europe.

Advertisement

“Global trends suggest continued sustained demand for animal health products in the years ahead,” Lechleiter continues. “Through this acquisition, which moves Elanco to top-tier in the industry, we intend to create value for our shareholders by adding to our promising pipeline of innovative animal health assets, increasing sales through a larger commercial footprint, and improving efficiencies and lowering costs.”

Specifically, the acquisition will create a greater commercial presence in the companion animal and swine markets for Elanco while also expanding the company’s presence in the equine and vaccines areas, even creating entry into the aquaculture market.

Lilly plans to fund the acquisition with approximately $3.4 billion of cash on hand and $2 billion in debt to be issued. The company expects improved efficiencies and reduced costs across both Elanco and Novartis Animal Health to save approximately $200 million per year within three years of deal closing—more than 10 percent of operating expenses from the combined businesses. The transaction is expected to close by the end of the first quarter of 2015, subject to antitrust clearance in the United States and other countries.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

Partners for Health Pets and VHMA collaboration publish white paper

Vetstoria releases its Fill Rate platform

What's new with the "Dentistry Lane" across the veterinary profession?

Meet the BlackDVM Network

View More Latest News
Advertisement